Home > The Group > BMJ media centre > Latest News > Is delaying premature delivery safe?

Is delaying premature delivery safe?

One professor questions the use of drugs that delay premature birth

Editorial: Tocolytics: do they actually work?
Research: Tocolytic therapy for preterm delivery: systematic review and network meta-analysis

An editorial published today on bmj.com asks if delaying premature labour is actually safe.

Professor Alfirevic from the Department of Women’s and Children’s Health at the University of Liverpool argues that although premature children tend to have lower cognitive ability than their peers and 14.9 million are born prematurely each year worldwide, is it really possible to stop spontaneous preterm labour?

In an accompanying research paper, Haas and colleagues carried out a review of several controlled trials to determine the most cost-effective tocolytic agent. Tocolytic drugs are used to delay delivery for up to 48 hours. This allows time for doctors to give steroids to speed up the baby’s lung development and to enable the mother to be transferred to a centre with a neonatal intensive care unit.

And while Professor Alfirevic appreciates that it is important to choose the right tocolytic drug, he argues that Haas and colleagues’ study found no evidence that tocolytic drugs improve rates of newborn illness or death.

Furthermore, a separate study which looked at mothers who took antibiotics (erythromycin and co-amoxiclav) to prevent premature birth found an unexpected increase in cerebral palsy among the children.

Professor Alfirevic suggests that instead of focusing studies on the success of tocolytic drugs on delaying preterm birth, larger trials are needed to determine the clinically meaningful effects of the drugs. He says that clinicians “need proof of a sustained improvement in important health outcomes that matter to women” and the evidence, that tocolytics may allow mothers more time to be moved to specialist neonatal units, may not be enough.

Professor Alfirevic says that despite Haas and colleagues’ “well done” meta-analysis, the Royal College of Obstetricians and Gynaecologists’ 2011 recommendation that it is reasonable not to use tocolytics still stands.

He concludes that clinicians should be honest and tell women that they are giving them drugs that they hope will prolong pregnancy, but they may not make their babies healthier. And he hopes that “babies are not coming to greater harm by our attempts to keep them in utero.”

http://bit.ly/SL8ppL

http://bit.ly/UOTiYb

Press Office
Contacts
BMJ enquiries
Email Emma Dickinson
+44 (0) 20 7383 6529

BMJ Journals enquiries
Email Caroline White
+44 (0) 798 0800 465
BMJ News Channel
BMJ Affinity
Best Practice